Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$260.71 USD

260.71
1,424,061

+2.88 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (159 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

CVS-Aetna Deal: What's Hot, What's Not

by Zacks Equity Research

CVS Health (CVS) and Aetna consolidation to add a new dimension to healthcare landscape. However, critics believe the gain will be short-lived for the healthcare society.

    Humana Partners Einstein Healthcare for Value-Based Care

    by Zacks Equity Research

    Humana (HUM) has been joining forces with other medical sector companies in order to strengthen its presence in value-based healthcare.

      Humana's Medicare Business Impresses, Public Exchange Hurts

      by Zacks Equity Research

      Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.

        Can Health Insurers Continue to Look Past ACA Threats in Q4?

        by Zacks Equity Research

        Despite regulatory challenges, health insurance companies have the potential to outperform in Q4 on growing demand for government plans, reduced uninsured rates and aging U.S. population.

          Anthem (ANTM) Grows on Membership, Rising Expenses Hurt

          by Zacks Equity Research

          Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.

            The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel

            by Zacks Equity Research

            The Zacks Analyst Blog Highlights: TOTAL S.A., Humana, Novo Nordisk, Target and Xcel

              Ensign Group (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y

              by Zacks Equity Research

              Ensign Group's (ENSG) earnings missed estimates in Q3 but grew year over year due to higher revenues.

                Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss

                by Zacks Equity Research

                Humana's (HUM) strong third-quarter earnings were driven by significantly low share count.

                  Anupama Mukhopadhyay headshot

                  Humana's (HUM) Q3 Earnings Beat, Revenues Miss

                  by Anupama Mukhopadhyay

                  Humana's (HUM) third quarter earnings beat estimates but revenues miss expectations.

                    Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?

                    by Zacks Equity Research

                    Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.

                      Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up

                      by Zacks Equity Research

                      Cigna's (CI) strong third-quarter earnings were driven by broad-based growth across its business segments.

                        Will Increased Visits Drive Teladoc's (TDOC) Q3 Earnings?

                        by Zacks Equity Research

                        Teladoc's (TDOC) earnings will benefit from its premier consumer engagement capabilities, broad network and scalable platform, which will increase visits and clients.

                          Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?

                          by Zacks Equity Research

                          Envision Healthcare's (EVHC) third-quarter earnings are likely to see a drag from high expenses, partly offset by increased revenues from its physician services segment.

                            Will Lower Health Care Revenues Mar Aetna (AET) Q3 Earnings?

                            by Zacks Equity Research

                            Aetna's (AET) third-quarter earnings are likely see a drain from lesser membership and low revenues in the Health Care segment, partly offset by benefits from share buyback and cost control.

                              Will Higher Admissions Aid HCA Healthcare (HCA) Q3 Earnings?

                              by Zacks Equity Research

                              HCA Healthcare's (HCA) third-quarter earnings are likely to be benefited by its inorganic growth measures partly offset by industry weakness.

                                Can Admissions Rise Fuel Universal Health (UHS) Q3 Earnings?

                                by Zacks Equity Research

                                Universal Health's (UHS) third-quarter results are likely to be driven by solid revenue growth in both its Acute Care and Behavioral Health segments.

                                  Can Enrollment Growth Drive Anthem (ANTM) in Q3 Earnings?

                                  by Zacks Equity Research

                                  Anthem's (ANTM) third-quarter results are likely to be aided by membership growth.

                                    Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?

                                    by Zacks Equity Research

                                    Centene (CNC) is expected to post better results in Q3 compared to Express Scripts (ESRX) on the back of solid revenue growth driven by rising membership.

                                      Can Medicaid Business Drive Centene's (CNC) Q3 Earnings?

                                      by Zacks Equity Research

                                      Centene's (CNC) third-quarter results are expected to be positively impacted by its Medicaid expansion initiatives.

                                        Humana Expands MA Offerings, Increases Benefits for Members

                                        by Zacks Equity Research

                                        Humana (HUM) continues to expand and restructure its Medicare Advantage plans in order to enhance the reach and quality of its offerings across the world.

                                          UnitedHealth (UNH) Beats Q3 Earnings on Higher Membership

                                          by Zacks Equity Research

                                          UnitedHealth (UNH) beats earnings in the third quarter driven by higher contribution from both its segments.

                                            WellCare (WCG) Unit Receives Favorable Star Ratings From CMS

                                            by Zacks Equity Research

                                            WellCare's (WCG) efforts to boost its Medicare business and provide its Medicare Advantage members quality services have helped it achieve favorable Star Quality ratings from CMS

                                              Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?

                                              by Zacks Equity Research

                                              The overall soft industry trends leading to low volume environment may continue to put a dampener on Quest Diagnostics (DGX) in Q3. The reimbursement scenario also remains a major cause for concern.

                                                Buy These 4 Momentum Stocks for Exciting Returns

                                                by Zacks Equity Research

                                                This screen will help you to get into momentum stocks that are storming ahead. Highlighted stocks include HUM, JBL, GBX and AMTD.

                                                  Anthem (ANTM) & Units Receive Medicare Star Ratings From CMS

                                                  by Zacks Equity Research

                                                  Anthem's (ANTM) focus on improving the quality of healthcare for its Medicare Advantage members has enabled it achieve favorable Star Ratings from CMS